首页 | 本学科首页   官方微博 | 高级检索  
检索        

胰高血糖素样肽-2对短肠大鼠残留小肠代偿的影响
引用本文:吴国豪,陈吉,李杭,吴肇汉.胰高血糖素样肽-2对短肠大鼠残留小肠代偿的影响[J].中华胃肠外科杂志,2006,9(5):441-444.
作者姓名:吴国豪  陈吉  李杭  吴肇汉
作者单位:200032,上海,复旦大学中山医院普通外科
摘    要:目的研究胰高血糖素样肽-2(GLP-2)对短肠大鼠残留小肠形态及功能代偿的影响。方法将20只切除小肠75%的大鼠随机分成对照组和GLP-2组,术后1-5 d内自由进食。GLP-2组每日2次腹腔注射GLP-2(250μg·kg~(-1)·d~(-1));对照组每日2次腹部皮下注射生理盐水0.5 ml;另设1组正常进食大鼠作空白对照。术后第6天行残留小肠黏膜形态学检测、细胞增殖核心抗原(PCNA)测定,钠葡萄糖共同转运体(SGLT1)和二肽转运体(PEPT1)的mRNA表达检测以及在体小肠循环灌流实验测定大鼠回肠的单位长度及单位重量的葡萄糖吸收率。结果GLP-2组残留小肠黏膜形态学指标、PCNA指数显著高于对照组;而小肠黏膜细胞凋亡显著低于对照组;残留回肠SGLT1和PEPT1的mRNA表达显著高于对照组;均P<0.05。但两组灌洗段回肠每g湿重葡萄糖吸收率差异无统计学意义(P>0.05)。结论GLP-2能刺激小肠黏膜上皮增生、抑制凋亡,促进短肠大鼠残留小肠黏膜的形态及功能代偿。

关 键 词:短肠综合征  胰高血糖素样肽-2  代偿  大鼠
收稿时间:2006-02-20
修稿时间:2006年2月20日

Effects of glucagon-like peptide 2 on the adaptation of residual small bowel in a rat model of short bowel syndrome
WU Guo-hao,CHEN Ji,LI Hang,WU Zhao-han.Effects of glucagon-like peptide 2 on the adaptation of residual small bowel in a rat model of short bowel syndrome[J].Chinese Journal of Gastrointestinal Surgery,2006,9(5):441-444.
Authors:WU Guo-hao  CHEN Ji  LI Hang  WU Zhao-han
Institution:Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China. prowugh@yahoo.com.cn
Abstract:OBJECTIVE: To investigate the effects of glucagon-like peptide 2 (GLP-2) on the morphology and functional adaptation of the residual small bowel in rat model of short bowel syndrome. METHODS: Twenty rats with 75% of the midjejunoileum removed were randomly divided into two groups, and received intra-peritoneal injection of GLP-2(250 micro*gd*kg-1*d-1) or subcutaneous injection saline(0.5 ml, twice one day) after operation. On postoperative day 6, the morphological changes of the residual jejunum and ileum, the expression of proliferating cell nuclear antigen(PCNA), and the mRNA expressions of Na-D-glucose cotransporters (SGLT1) and peptide cotransporters (PEPT1) were determined. The intestinal glucose absorption data per unit length as well as per unit weight of ileum were measured by in vivo circulatory perfusion experiment. RESULTS: The morphological parameters of the residual gut such as the thickness of mucosa, height of villus, depth of crypt, and PCNA positive index were significantly higher, while the apoptosis rate per unit of mucosal square was significantly lower in GLP-2 treatment group than those in the control group. The expressions of mRNA SGTLl and PEPT1 in the residual ileum were significantly higher than those in the control group. There was no significant difference in glucose absorption rate per gram of mucosal wet weight between the two groups (P > 0.05). CONCLUSION: GLP-2 could improve morphological and functional adaptation of the residual small bowel by stimulating enterocyte proliferation and decreasing enterocyte apoptosis in short bowel syndrome.
Keywords:Short bowel syndrome  Glucagon-like peptide 2  Adaptation  Rats
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号